Kliničke studije za Migrena u državi Illinois
6 studija za Migrena traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Chicago Headache Center & Research Institute /ID# 248625, Chicago
- Ascension Saint Alexius /ID# 275261, Hoffman Estates
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Cedar Crosse Research Center, Chicago
- Chicago Headache Center & Research Institute, Chicago
- Healthcare Research Network II, LLC, Flossmoor
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07645924Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Chicago Headache Center & Research Inst /ID# 272345, Naperville
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. velj 2026. · NCT07310290Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
- Advocate Christ Medical Center Emergency Department, Oak Lawn
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. sij 2026. · NCT06904287Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.